1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Effect of Cyclosporine on Cytokine Production in Elective Coronary Artery Bypass Grafting : A Sub-Analysis of the CiPRICS (Cyclosporine to Protect Renal Function in Cardiac Surgery) Study
(
- Contribution to journal › Article
-
Mark
Reduced renal elimination of larger molecules is a strong predictor for mortality
(
- Contribution to journal › Article
- 2019
-
Mark
The mortality increase in cardiac surgery patients associated with shrunken pore syndrome correlates with the eGFR
cystatin C
/eGFR
creatinine
-ratio
(
- Contribution to journal › Article
- 2018
-
Mark
Cyclosporine before Coronary Artery Bypass Grafting Does Not Prevent Postoperative Decreases in Renal Function : A Randomized Clinical Trial
(
- Contribution to journal › Article
- 2016
-
Mark
Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting.
(
- Contribution to journal › Article
-
Mark
The predictive value of s-cystatin C for mortality after coronary artery bypass surgery
(
- Contribution to journal › Article
-
Mark
Ciclosporin to Protect Renal function In Cardiac Surgery (CiPRICS) : A study protocol for a double-blind, randomised, placebo-controlled, proof-of-concept study
(
- Contribution to journal › Article
- 2014
-
Mark
Erythropoietin and Protection of Renal Function in Cardiac Surgery (the EPRICS Trial).
(
- Contribution to journal › Article